Skip to main content

Ensuring a Resilient US Prescription Drug Supply - The CIDRAP Viewpoint

Submitted by [email protected] on November 4, 2020 - 11:50 AM

This report identifies issues that lead to pharmaceutical shortages in the United States and provides recommendations to ensure the United States maintains an adequate supply of pharmaceuticals.

Content Source:

CIDRAP

Content Author:

Stephen W. Schondelmeyer, PharmD, PhD, MPubAdm; James Seifert, JD, MPH, MS; David J. Margraf, PharmD, MS; Melissa Mueller, MPH; Ian Williamson, MBA; Chris Dickson; Divya Dasararaju, MS; Claire Caschetta; Nicholas Senne; Michael T. Osterholm, PhD, MPH

Tags: